Perception of risk of adverse drug reactions by medical students: Influence of a 1 year pharmacological course

British Journal of Clinical Pharmacology

Volumn 64, Issue 2, 2007, Pages 233-236

  Durrieu, G ^a,b   Hurault, C ^a   Bongard, V ^c   Damase Michel, C ^a,b   Montastruc, J L ^a,b  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

Author keywords

Adverse drug reactions; Medical students; Pharmacovigilance; Risk; Social pharmacology

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CONTRACEPTIVE AGENT; CORTICOSTEROID; HYPNOTIC AGENT; HYPOCHOLESTEROLEMIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TRANQUILIZER;

ADULT; ADVERSE OUTCOME; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL EDUCATION; MEDICAL STUDENT; NORMAL HUMAN; PERCEPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; COHORT STUDIES; EDUCATION, MEDICAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PHARMACOLOGY;

EID: 34447525365     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02882.x     Document Type: Article

References (12)

1. Bongard V, Ménard-Taché S, Bagheri H, Kabiri K, Lapeyre-Mestre M, Montastruc JL. Perception of the risk of adverse drug reactions. Differences between health professionals and non-health professionals. Br J Clin Pharmacol 2002 54 : 433 6.
2. Cullen G, Kelly E, Murray FE. Patients' knowledge of adverse reactions to current medications. Br J Clin Pharmacol 2006 62 : 232 6.
3. Montastruc JL, Bongard V, Lapeyre-Mestre M. Perception of the risk of gastrointestinal adverse drug reactions with non-steroidal anti-inflammatory drugs (including coxibs): differences among general practitioners, gastroenterologists and rheumatologists. Eur J Clin Pharmacol 2003 59 : 685 8.
4. Grove ML, Hassel AB, Hay EM, Shadforth MF. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. Q J Med 2001 94 : 309 19.
5. Cosentino M, Leoni O, Oria C, Michielotto D, Massino E, Lecchini S, Frigo G. Hospital-based survey of doctors' attitudes to adverse drug reactions and perception of drug-related risk for adverse reaction occurrence. Pharmacoepidemiol Drug Safety 1999 8 : S27 S35.
6. Montastruc JL. Social pharmacology: a new topic in clinical pharmacology. Thérapie 2002 57 : 420 6.
7. Ngoundo Mbongue TB, Sommet A, Pathak A, Montastruc JL. 'Medicamentation' of society, non-diseases and non-medications: a point of view from social pharmacology. Eur J Clin Pharmacol 2005 61 : 309 13.
8. Pouyanne P, Haramburu F, Imbs JL, Bégaud B. Admissions to hospital caused by adverse reactions: cross sectional incidence study. Br Med J 2000 320 : 1036.
9. European Medical Agency. Press release. EMEA 6 October 2004. Statement following withdrawal of Vioxx (Rofecoxib) : Website. http://www.emea.eu.int.
10. Anonymous. How to avoid future Vioxx-type scandals. Prescribe Int 2005 14 : 115 7.
11. European Medical Agency. CHMP - EMEA public statement on recent publications regarding hormone replacement therapy, 3 December 2003. Website: http://www.emea.eu.int.
12. European Medical Agency. CHMP-EMEA. Questions and answers on paroxetine. Revised version following the CHMP meeting of 8 December 2004. Website: http://www.emea.eu.int.